Inhibrx

INBX13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying INBX

Top funds mostly trimmed Inhibrx in Q2 (Apr⁠–⁠Jun)

Buying:

FundsInsiders3Congress

Top funds
0 of 1 bought more, 1 sold some. Largest: Viking Global Investors, $106.5M (0% of its portfolio).
Insiders
3 insiders bought, 2 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

1 fund$106.5M held0.3% avg. weightQ2: 0 bought / 1 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 11 filings

Net buying$19.44M

Date	Insider	Type	Shares	Price	Value
Oct 14, 2026	Mark Lappe CEO	Bought	10,040	$84.56	$849K
Sep 25, 2026	Mark Lappe CEO	Bought	10,000	$99.88	$999K
Sep 23, 2026	Jon Faiz Kayyem Director	Bought	5,000	$100.00	$500K
Sep 16, 2026	Jon Faiz Kayyem Director	Bought	5,000	$100.00	$500K
Sep 11, 2026	Kimberly Manhard Director	Sold	1,500	$109.03	$164K
Sep 8, 2026	Kimberly Manhard Director	Sold	1,000	$115.47	$115K
Sep 8, 2026	Jon Faiz Kayyem Director	Bought	5,000	$113.52	$568K
Sep 8, 2026	Douglas Forsyth Director	Bought	2,500	$114.65	$287K
Sep 8, 2026	Mark Lappe CEO	Bought	25,000	$105.82	$2.65M
Oct 7, 2025	Viking Global Investors LP 10% Owner	Sold	350,000	$32.25	$11.29M
Nov 19, 2024	Jon Faiz Kayyem Director	Bought	107,186	$14.21	$1.52M